Evaluating Clinical Biomarkers for Testing Therapeutics in Patients

Time: 8:45 am
day: Day Two


  • Understanding the value of novel clinical biomarkers and candidate endpoints for evaluating novel therapeutics
  • Understanding how to make technical evaluations, and what data is needed to support their qualification and validation
  • Understanding the expectations from regulatory authorities and clinicians in this field